Veterinary API

This product is mainly used for pneumonia, bronchitis, pharyngitis, tonsillitis, pyelonephritis, urinary tract infection, gonococcal urethritis, cholecystitis, cholangitis, gynecological infection, sepsis and otitis media caused by Streptococcus, pneumococcus and other sensitive bacteria.

An agonist of RECEPTORS, ADRENERGIC ALPHA-2 that is used in veterinary medicine for its analgesic and sedative properties. It is the racemate of DEXMEDETOMIDINE.

Ciprofloxacin hydrochloride is suitable for urinary tract infection, moderate and severe respiratory tract infection, intestinal infection, skin and soft tissue infection, sepsis and intraperitoneal infection caused by sensitive bacteria.

Broad spectrum antiparasitic drugs. It is used to control pests of animals such as cattle (Boophilus and mioroplus), including resistant strains, and can also be used to control crop pests.

Nevirapine is a non nucleoside reverse transcriptase inhibitor, which blocks RNA dependent and DNA dependent DNA polymerase activity by directly connecting with HIV-1 reverse transcriptase (RT) and breaking the catalytic end of the enzyme. It does not compete with substrate or nucleoside triphosphate, and can be combined with other antiretroviral drugs to treat HIV-1 infection. In June 1996, it was approved by the U.S. Food and Drug Administration (FDA) to treat adult HIV infection with nucleoside drugs. At present, common adverse reactions include skin rash, abnormal liver function, fatigue, fever, headache, drowsiness, gastrointestinal adverse reactions and myalgia. Severe liver injury, liver failure and allergic reaction. In January 2005, FDA released a message on its official website to remind medical staff that patients with high CD4 cell count (male > 400 / mm3, female > 250 / mm3) have a higher risk of liver injury. Therefore, for patients who have not received antiviral therapy before, if the CD4 cell count is higher than the above two limits, nevirapine should be avoided.